The study aims to find out if adding a special treatment, called *ultrasound-guided hydrorelease*, helps people with *adhesive capsulitis* (a condition where the shoulder stiffens and hurts) who are already getting *ultrasound-guided hydrodilatation*. This is a **double-blind**, *randomized controlled trial*. This means neither the patients nor the doctors know who gets which treatment to ensure fairness. The study involves patients aged 30-70 who have had shoulder pain and stiffness for at least 3 months.

• **Length & Visits:** Participants will be checked before, immediately after, and then at 1 week, 1 month, and 2 months.
• **Treatment:** Two groups: one gets the standard treatment, and the other gets an additional injection in a shoulder ligament.
• **Risks & Compensation:** The study doesn't mention specific risks or compensation, but it's important to ask about this if you consider participating.

Some conditions like recent shoulder treatment, certain diseases, or pregnancy might disqualify you. Doctors will monitor shoulder pain and movement using tools like the *Shoulder Disability Index*. If you're interested, make sure you meet the criteria and discuss any concerns with the study team! 😊